Search

Your search keyword '"Metanephrine urine"' showing total 427 results

Search Constraints

Start Over You searched for: Descriptor "Metanephrine urine" Remove constraint Descriptor: "Metanephrine urine" Language english Remove constraint Language: english
427 results on '"Metanephrine urine"'

Search Results

1. Reference intervals for urinary metanephrines to creatinine ratios in dogs in Japan.

2. [Pheochromocytoma. Preoperative approach].

3. Preoperative prediction of metastatic pheochromocytoma and paraganglioma using clinical, genetic, and biochemical markers: A cohort study.

4. Clinical Significance of Pheochromocytoma Size on the Timing and Extent of Surgery.

5. Reference intervals for deconjugated urine metanephrines by Bhattacharya analysis.

6. 24-hour urine metanephrine excretion in patients diagnosed with adrenal incidentaloma: impact of commonly used drugs on a clinical decision.

7. Biochemical Assessment of Pheochromocytoma and Paraganglioma.

8. Pediatric total fractionated metanephrines: age-related reference intervals in spot urine.

9. Optimising urinary catecholamine metabolite diagnostics for neuroblastoma.

10. Plasma and urinary metanephrine and normetanephrine concentrations using liquid chromatography with tandem mass spectrometry in healthy cats and in a cat with pheochromocytoma.

11. Comparison of Patients with Atrial Fibrillation Without Structural Heart Disease and Normal Population In Terms of Urine Catecholamines.

12. The clinical utility of plasma and urine metanephrines in hypertensive emergency.

13. Dual-Template Magnetic Molecularly Imprinted Polymer for Simultaneous Determination of Spot Urine Metanephrines and 3-Methoxytyramine for the Diagnosis of Pheochromocytomas and Paragangliomas.

14. Verifying Clinically Derived Reference Intervals for Daily Excretion Rates of Fractionated Metanephrines Using Modern Indirect Reference Interval Models.

15. Risk factors for intraoperative complications in pheochromocytomas.

16. Inpatient Measurements of Urine Metanephrines are Indistinguishable from Pheochromocytoma: Retrospective Cohort Study.

17. Properly Collected Plasma Metanephrines Excludes PPGL After False-Positive Screening Tests.

18. Predictors of Hypotension after Adrenalectomy for Pheochromocytoma.

19. Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma.

20. Hypertensive Heartbreak.

21. Multivariate Statistical Approach for Nephrines in Women with Obesity.

22. Quantitation using HRMS: A new tool for rapid, specific and sensitive determination of catecholamines and deconjugated methanephrines metanephrines in urine.

23. False elevations in urinary metanephrines: under-recognised pitfall with 24-hour urinary volume collection.

24. Pheochromocytoma crisis in a patient with newly diagnosed neurofibromatosis type 1.

25. Pheochromocytoma: A three-decade clinical experience in a multicenter study.

26. Detection of spot urinary free metanephrines and 3-methoxytyramine with internal reference correction for the diagnosis of pheochromocytomas and paragangliomas.

27. Screening for phaeochromocytoma in patients with acute cerebrovascular disease: Is it necessary?

28. Random 'spot' urinary metanephrines compared with 24-h-urinary and plasma results in phaeochromocytomas and paragangliomas.

29. Case report of a phantom pheochromocytoma.

30. Biochemistry may be misleading in metachronous MEN2A-associated phaeochromocytoma following unilateral total adrenalectomy.

31. Clinical factors affecting spot urine fractionated metanephrines in patients suspected pheochromocytoma/paraganglioma.

32. Simple, rapid, and cost-effective microextraction by the packed sorbent method for quantifying of urinary free catecholamines and metanephrines using liquid chromatography-tandem mass spectrometry and its application in clinical analysis.

33. Incidental giant cystic pheochromocytoma: a case report and review of the literature.

34. Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option?

35. Pheochromocytoma: An approach to diagnosis.

36. Very high rate of false positive biochemical results when screening for pheochromocytoma in a large, undifferentiated population with variable indications for testing.

37. Association between higher urinary normetanephrine and insulin resistance in a Japanese population.

38. Development and validation of a clinical model to predict intraoperative hemodynamic instability in patients with pheochromocytomas surgery.

39. No effect of acidification or freezing on urinary metanephrine levels.

40. Correlation between urinary fractionated metanephrines in 24-hour and spot urine samples for evaluating the therapeutic effect of metyrosine: a subanalysis of a multicenter, open-label phase I/II study.

41. Pheochromocytoma: Positive predictive values of mildly elevated urinary fractionated metanephrines in a large cohort of community-dwelling patients.

42. Pheochromocytoma and Pregnancy.

43. Change of skeletal muscle mass in patients with pheochromocytoma.

44. Clonidine suppression testing for pheochromocytoma in neurofibromatosis type 1.

45. Glucose homeostasis in major depression and schizophrenia: a comparison among drug-naïve first-episode patients.

46. Performance of plasma free metanephrines in diagnosis of pheochromocytomas and paragangliomas in the population of Asturias.

47. Electrical Remodeling of Ventricular Repolarization Abnormality after Treatment in Pheochromocytoma: U Wave Finding in a Retrospective Analysis.

48. Plasma free metanephrines for diagnosis of neuroblastoma patients.

49. Reference intervals for LC-MS/MS measurements of plasma free, urinary free and urinary acid-hydrolyzed deconjugated normetanephrine, metanephrine and methoxytyramine.

50. Differences in the actions of adrenaline and noradrenaline with regard to glucose intolerance in patients with pheochromocytoma.

Catalog

Books, media, physical & digital resources